Access 2.8M+ Filings Sign Up Free
Oryzon Genomics S.A. Logo

Oryzon Genomics S.A. | ORY - Profile, Filings, Stock Info & Investor Relations Data

Oryzon Genomics S.A. | ORY
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Spain
Founded
2000
Oryzon Genomics S.A. (ORY)

Company Profile

Website
Investor Relations

About Oryzon Genomics S.A.

Founded in 2000 in Barcelona, Spain, Oryzon is a clinical stage biopharmaceutical company considered as the European champion in Epigenetics. Oryzon has one of the strongest portfolios in the field. Oryzon’s LSD1 program has rendered two compounds Vafidemstat and Iadademstat in Phase II clinical trials. In addition, Oryzon has ongoing programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurodegenerative diseases. Oryzon has offices in Spain and the United States.

Employees

43

Market Presence

Europe + North America

Headquarters

Sant Ferran 74
08940, Cornellà de Llobregat
Spain

Oryzon Genomics S.A. (ORY)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Oryzon Genomics S.A. (ORY)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Oryzon Genomics S.A. (ORY)
Stock & Investor Information

ISINs

ES0167733015

LEI

95980063R15RDF29DK13

Stock Exchange Listings

Bolsa de Madrid

Industry Classification

Sector
Health Care
Industry
Biotechnology